TCL Archive More Patients Get Screened, Colorectal Death Rates Drop By Cancer History Project July 29, 2011
TCL Archive Revlimid Shows 91 Percent Response in Non-Hodgkin’s By Cancer History Project July 29, 2011
TCL Archive Revlimid Also Demonstrates Response in Mantle Cell By Cancer History Project July 29, 2011
TCL Archive FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response By Cancer History Project July 29, 2011
TCL Archive Overall Cancer Mortality Rates Higher For Men Than Women By Cancer History Project July 29, 2011
TCL Archive New Model For Risk Assessment Includes Alcohol, Exercise, Weight By Cancer History Project July 29, 2011
TCL Archive Researchers Identify Five Genes Associated With Melanoma Risk By Cancer History Project July 29, 2011
TCL Archive Stereotactic Body Radiotherapy Could Improve Overall Survival By Cancer History Project July 29, 2011
Article Robert Mayer talks about the half-century of misses that preceded the development of daraxonrasib By Cancer History Project
